ABT

2024Q4BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2025-01-22 · Fiscal end 2024-12-31 · Features as of 2025-01-21

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.34
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move0.8%
IV front—
P/C full—
P/C front—
Features as of2025-01-21

Run-up

Close—
Ret 5d+3.2%
Ret 10d+2.6%
Ret 20d+4.3%
Ret 30d+0.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.34—
Estimated EPS1.34
Actual revenue
11.0B
Surprise %0.0%
Beat / miss—
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+3.2%
Implied vs actual

Implied 0.8%Actual 2.3%

Gap reaction-2.3%
Day result+0.8%
Next-day upYes
Realized / IV2.70×

Post tape

Post 5d+8.6%
Post 10d+12.1%
Post volume13.2M
Vol ×10d2.34×
Vol ×20d2.57×
Post range5.6%